EP4121522 - METHODS AND COMPOSITIONS FOR DIRECTED GENOME EDITING [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.12.2022 Database last updated on 31.08.2024 | |
Former | The international publication has been made Status updated on 07.06.2022 | Most recent event Tooltip | 22.05.2024 | Supplementary search report | published on 19.06.2024 [2024/25] | Applicant(s) | For all designated states Intellia Therapeutics, Inc. 40 Erie Street Cambridge, MA 02139 / US | [2023/04] | Inventor(s) | 01 /
HALPERIN, Schaked Omer 1250 Powell Street, Apartment 4 Emeryville, California 94608 / US | [2023/04] | Representative(s) | Schlich, George William, et al Schlich 9 St. Catherine's Road Littlehampton, West Sussex BN17 5HS / GB | [N/P] |
Former [2023/04] | Schlich, George, et al Schlich 9 St Catherine's Road Littlehampton, West Sussex BN17 5HS / GB | Application number, filing date | 21771405.4 | 18.03.2021 | [2023/04] | WO2021US23041 | Priority number, date | US202062992032P | 19.03.2020 Original published format: US 202062992032 P | US202063055829P | 23.07.2020 Original published format: US 202063055829 P | US202163153161P | 24.02.2021 Original published format: US 202163153161 P | [2023/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021188840 | Date: | 23.09.2021 | Language: | EN | [2021/38] | Type: | A1 Application with search report | No.: | EP4121522 | Date: | 25.01.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.09.2021 takes the place of the publication of the European patent application. | [2023/04] | Search report(s) | International search report - published on: | US | 23.09.2021 | (Supplementary) European search report - dispatched on: | EP | 21.05.2024 | Classification | IPC: | C12N9/12, C12N9/22, C12N15/11, C12N15/52, C12N15/90 | [2024/14] | CPC: |
C12N9/22 (EP,KR,US);
C12N9/1276 (EP,KR,US);
C12N15/11 (US);
C12N15/111 (EP);
C12N15/113 (KR,US);
C12N15/52 (EP,US);
C12N15/907 (EP,KR,US);
C12N2310/122 (KR,US);
C12N2310/123 (EP,KR);
C12N2310/128 (EP,KR);
C12N2310/20 (EP,KR,US);
C12N2310/3519 (EP,KR,US);
|
Former IPC [2023/04] | C12N9/12, C12N9/22 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/04] | Title | German: | VERFAHREN UND ZUSAMMENSETZUNGEN ZUR GERICHTETEN GENOMEDITIERUNG | [2023/04] | English: | METHODS AND COMPOSITIONS FOR DIRECTED GENOME EDITING | [2023/04] | French: | MÉTHODES ET COMPOSITIONS POUR L'ÉDITION GÉNOMIQUE DIRIGÉE | [2023/04] | Entry into regional phase | 03.10.2022 | National basic fee paid | 03.10.2022 | Search fee paid | 03.10.2022 | Designation fee(s) paid | 03.10.2022 | Examination fee paid | Examination procedure | 03.10.2022 | Examination requested [2023/04] | 20.04.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 03.10.2022 | Renewal fee patent year 03 | 27.03.2024 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2002192788 (IHLENFELDT HANS-GEORG [DE], et al); | [Y]US2014010839 (BENKIRANE MONSEF [FR], et al); | [X]WO2018049168 (UNIV LELAND STANFORD JUNIOR [US]); | [Y]US2018230494 (JOUNG J KEITH [US], et al); | [X]US2018237770 (MAY ANDREW PAUL [US], et al); | [Y]US2018298414 (JANULAITIS ARVYDAS [LT], et al); | [Y]US2018313843 (KEPPLER OLIVER TILL [DE], et al); | [A]US2019062409 (LUBAN JEREMY [US]); | [Y]WO2019070843 (UNIV TEXAS [US]); | [XY]US2019350978 (BEAUCHESNE PASCAL [US], et al); | [X]WO2020012335 (ALIA THERAPEUTICS S R L [IT]); | [Y]US2020038424 (HIRANO MICHIO [US], et al); | [XY]WO2020047124 (FLAGSHIP PIONEERING INC [US]); | [X]WO2020051561 (BEAM THERAPEUTICS INC [US]); | [PX]WO2020191153 (BROAD INST INC [US], et al); |